Pete, the details you are asking for are in the company announcements.
iX Biopharama (manufacturers of the wafer) are a Singaporean listed company, the extract will be imported from Linnea SA (the Swiss company they are partnered with).
Background can be found in their initial agreement announcement with IX Biopharma:
http://www.asx.com.au/asxpdf/20180104/pdf/43qm501y83dl43.pdf
background on why they're doing phase I trials and potential product uses here:
http://www.asx.com.au/asxpdf/20170821/pdf/43lkmdgl66r7vx.pdf
background on revenue and sales growth here:
http://www.asx.com.au/asxpdf/20171213/pdf/43q4cfhr8lj3xb.pdf
Pete, the details you are asking for are in the company...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable